Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - HESKA CORPFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - HESKA CORPR3.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR5.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR2.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR8.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR1.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR7.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR6.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR9.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR21.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR10.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR18.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR17.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR16.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR12.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR19.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR20.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR14.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR13.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR15.htm
EX-31.2 - CFO CERTIFICATION - HESKA CORPex31-2.htm
EX-31.1 - CEO CERTIFICATION - HESKA CORPex31-1.htm
10-Q - FORM 10Q - HESKA CORPform10q.htm
XML - IDEA: XBRL DOCUMENT - HESKA CORPR11.htm
EX-32.1 - CEO AND CFO CERTIFICATION - HESKA CORPex32-1.htm
v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenue, net:        
Core companion animal health $ 13,530 $ 14,263 $ 45,811 $ 44,727
Other vaccines, pharmaceuticals and products 3,376 3,345 8,541 9,833
Total revenue, net 16,906 17,608 54,352 54,560
Cost of revenue 10,180 10,781 30,655 31,966
Gross profit 6,726 6,827 23,697 22,594
Operating expenses:        
Selling and marketing 4,381 3,753 14,020 11,283
Research and development 180 311 717 1,345
General and administrative 2,192 2,355 7,522 7,131
Total operating expenses 6,753 6,419 22,259 19,759
Operating income (27) 408 1,438 2,835
Interest and other (income) expense, net (16) (64) 69 101
Income before income taxes (11) 472 1,369 2,734
Current tax expense 16 30 98 189
Deferred tax expense (benefit) 5 154 457 884
Total income tax expense (benefit) 21 184 555 1,073
Net income $ (32) $ 288 $ 814 $ 1,661
Basic net income (loss) per share $ (0.01) $ 0.06 $ 0.15 $ 0.32
Diluted net income (loss) per share $ (0.01) $ 0.05 $ 0.15 $ 0.31
Weighted average outstanding shares used to compute basic net income (loss) per share 5,350,000 5,239,000 5,314,000 5,235,000
Weighted average outstanding shares used to compute diluted net income (loss) per share 5,350,000 5,411,000 5,503,000 5,337,000